Triple
T19773600
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Teva Pharmaceutical Industries |
E474949
|
entity |
| Predicate | acquired |
P2511
|
FINISHED |
| Object | Cephalon |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cephalon | Statement: [Teva Pharmaceutical Industries, acquired, Cephalon]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cephalon Context triple: [Teva Pharmaceutical Industries, acquired, Cephalon]
-
A.
Mylan
Mylan is a global generic and specialty pharmaceuticals company known for producing a wide range of affordable medicines and healthcare products.
-
B.
Purdue Pharma
Purdue Pharma is an American pharmaceutical company best known for developing and aggressively marketing the prescription painkiller OxyContin, which has been widely implicated in the U.S. opioid epidemic.
-
C.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
D.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
-
E.
Sandoz
Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Cephalon Target entity description: Cephalon was a biopharmaceutical company known for developing and marketing specialty drugs in areas such as central nervous system disorders, pain management, and oncology.
-
A.
Mylan
Mylan is a global generic and specialty pharmaceuticals company known for producing a wide range of affordable medicines and healthcare products.
-
B.
Purdue Pharma
Purdue Pharma is an American pharmaceutical company best known for developing and aggressively marketing the prescription painkiller OxyContin, which has been widely implicated in the U.S. opioid epidemic.
-
C.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
D.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
-
E.
Sandoz
Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e51a43a08190956bc6df13c91a77 |
completed | April 10, 2026, 11:55 a.m. |
| NER | Named-entity recognition | batch_69e6535e450c8190a2628245ae0d0bd3 |
completed | April 20, 2026, 4:25 p.m. |
Created at: April 10, 2026, 1:48 p.m.